Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

Page 74

Activism

Moody's May Downgrade Bed, Bath Bonds

By Greg Morcroft
|
Published: October 29th, 2019
The rating agency said Bed Bath's transformation is taking longer than expected because others stole a jump on the company when evolving in an increasingly fast-changing retail landscape.
M&A

FTC to Closely Examine Pfizer, Mylan Deal

By David Hatch
|
Published: October 29th, 2019
The transaction faces other regulatory hurdles, including a review by China, possible Brexit complications and clearances in nearly two dozen jurisdictions.